Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 APC Expands Dublin Facilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

APC Expands Dublin Facilities

Will add 50 new research and development positions

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

APC, a research and development company based in Ireland, has completed a €10 million investment, expanding its facilities at its headquarters in Cherrywood, Dublin, and resulting in 50 new research and development positions at the facility.

APC partners with the pharmaceutical and biotech industry to support the development of life- saving medicines. The company is currently working on more than 20 medicines for a variety of cancers, respiratory diseases, Alzheimer’s and HIV.

The company currently employs 120 people, the majority of which are chemical engineers, process and biopharmaceutical scientists. The new facility will bring the total sq.-ft. to 60,000 at the Cherrywood HQ, with staff numbers expected to increase by over 40% by the end of 2019.

Mark Barrett, chief executive officer of APC, said the investment represents APC’s continued expansion into new and emerging therapies and technologies such as viral, gene and cell therapies. “We are also delighted that the new facility with Bavarian Nordic will enforce our stated mission of accelerating the development of quality, life-changing medicines to patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics